Summary
Aflac Inc.'s 2005 10-K report highlights a strong financial performance, with total revenues reaching $14.36 billion and net earnings of $1.48 billion. The company's core business remains supplemental health and life insurance, with a significant portion of its operations and assets concentrated in Japan (74% of revenues and 82% of assets). Aflac Japan continues to be the primary growth driver, showing robust premium income and pretax operating earnings, aided by favorable demographic trends and increasing consumer demand for health-related insurance products. In the U.S., Aflac also demonstrated solid growth in premium income and operating earnings, driven by its accident/disability and cancer expense products. The company emphasizes its distinct market position through its worksite marketing strategy and portable, individually underwritten policies. Management is focused on enhancing its distribution system and sales associate training to ensure continued growth and operational efficiency across both key markets.
Key Highlights
- 1Total revenues increased to $14.36 billion in 2005, up from $13.28 billion in 2004.
- 2Net earnings grew to $1.48 billion in 2005, compared to $1.27 billion in 2004.
- 3Aflac Japan accounted for a substantial majority of the company's financial performance, with 74% of total revenues and 82% of total assets.
- 4Annualized premiums in force for Aflac Japan grew by 6.8% in yen terms, reflecting strong policy persistency and new sales.
- 5Aflac U.S. saw a 10.0% increase in annualized premiums in force, driven by its accident/disability and cancer expense products.
- 6The company's financial strength ratings remained strong, with ratings of AA from Standard & Poor's and Fitch Ratings, and Aa2 from Moody's.
- 7Aflac continued its share repurchase program, demonstrating a commitment to returning value to shareholders.